# Tranexamic Acid in Cyanotic Heart Defects

> **NCT03244423** · PHASE2 · COMPLETED · sponsor: **Assiut University** · enrollment: 120 (actual)

## Conditions studied

- Postoperative Hemorrhage

## Interventions

- **DRUG:** Normal saline at induction
- **DRUG:** Normal saline infusion
- **DRUG:** Intravenous tranexamic acid
- **DRUG:** infusion tranexamic acid
- **DRUG:** topical tranexamic acid
- **DRUG:** topical normal saline

## Key facts

- **NCT ID:** NCT03244423
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2017-08
- **Final completion:** 2017-08
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2018-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03244423

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03244423, "Tranexamic Acid in Cyanotic Heart Defects". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT03244423. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*